Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-26 @ 11:49 AM
Ignite Modification Date: 2025-12-26 @ 11:49 AM
NCT ID: NCT04584216
Eligibility Criteria: Inclusion Criteria: 1. Males or females aged from 20 to 69 years old (both inclusive). 2. Participants who use VDTs, including laptops, electronic tablets, readers and smartphones for 6 hours or more a day. 3. Participants who respond to the 16 symptoms of visual symptoms related to computer use in the working population for the total score over 6 based on a computer vision syndrome questionnaire. 4. Participants who respond to more than 1 of 12 typical dry eye symptoms by "constantly" or "often" based on a dry eye questionnaire. 5. Participants are able and willing to comply with all protocol requirements and procedures. 6. Participants who must be capable of providing informed consent document, with one's signature. Exclusion Criteria: 1. Participants with eye diseases that could affect the ocular surface (e.g. Ocular inflammation, infectious conjunctivitis, allergic diseases, autoimmune diseases and collagen diseases). 2. Participants who have been treated by physicians because of eye diseases and do not recover from that disease yet at the moment of joining to this study, or participants who need to be treated by physicians because of eye disease. 3. Participants with the excessive meibomian lipid secretion (seborrheic MGD). 4. Participants with trauma, swelling and eczema at the skin around eyes. 5. Participants with allergic reaction for heating, abnormality of the heat or depression of the heat. 6. Participants who are deemed inappropriate to participate in this study by physicians.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 20 Years
Maximum Age: 69 Years
Study: NCT04584216
Study Brief:
Protocol Section: NCT04584216